{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:59:55Z","timestamp":1773763195170,"version":"3.50.1"},"reference-count":28,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T00:00:00Z","timestamp":1047427200000},"content-version":"vor","delay-in-days":345,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Ophthalmologica Scandinavica"],"published-print":{"date-parts":[[2002,4]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title><jats:p><jats:bold>Purpose:\u2002<\/jats:bold> To compare the frequency of cataract development in bone marrow transplanted children who have been given either total body irradiation (TBI) or busulphan as conditioning treatment before bone marrow transplantation (BMT).<\/jats:p><jats:p><jats:bold>Material and  methods:\u2002<\/jats:bold> Forty\u2010five children who underwent BMT between 1987 and 1994 were included in the study. Twenty\u2010one children were conditioned with TBI and 24 with busulphan before BMT. All children underwent an ophthalmic examination before BMT in order to exclude lens opacities. Yearly examinations for 2\u201310\u2003years were performed after BMT.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Cataracts developed in 20 of the 21 (95%) children conditioned with TBI and in five of the 24 (21%) children conditioned with busulphan. There was no relationship between cataract development and age at BMT, or between cataract development and prednisolone given before or after BMT.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> The present study confirms earlier reports of the high risk of cataract development after TBI and suggests that busulphan is related to cataract development, although less frequently than TBI. The report discusses the possible additive effect of the disease itself, of any corticosteroid treatment and of other cytostatic drugs. It then stresses the importance of early diagnosis of cataracts in children in order to prevent the development of amblyopia.<\/jats:p>","DOI":"10.1034\/j.1600-0420.2002.800217.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:19:12Z","timestamp":1047352752000},"page":"211-215","source":"Crossref","is-referenced-by-count":30,"title":["Cataract in children after bone marrow transplantation: relation to conditioning regimen"],"prefix":"10.1111","volume":"80","author":[{"given":"Gerd","family":"Holmstr\u00f6m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Borgstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berit","family":"Calissendorff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,3,12]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1159\/000206064"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1960.63030020005014"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood.V79.10.2578.bloodjournal79102578","article-title":"Allogeneic bone marrow transplantation for acute myeloid leukaemia in first remission: a randomized trial of busulphan\u2010Cytoxan versus Cytoxan\u2010total body irradiation as preparative regimen. (A d'\u00c9tude de la Greffe de Moelle Osseuse report.)","volume":"79","author":"Blaise D","year":"1992","journal-title":"Blood"},{"key":"e_1_2_6_5_1","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1182\/blood.V81.8.2187.2187","article-title":"A prospective randomized comparison of total body irradiation\u2010ectoposide versus busulphan\u2010cyclophosphamide as preparative regimens for bone marrow transplantation in patients with leukaemia who were not in first remission. (A South\u2010west Oncology Group study.)","volume":"81","author":"Blume KG","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.75.10.611"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.77.1.36"},{"key":"e_1_2_6_8_1","first-page":"427","article-title":"The development of cataract in children as a late side\u2010effect of bone marrow transplantation","volume":"7","author":"Calissendorff B","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_9_1","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1182\/blood.V84.6.2036.2036","article-title":"Marrow transplantation for chronic myeloid leukaemia: a randomized study comparing cyclophosphamide and total body irradiation with busulphan and cyclophosphamide","volume":"84","author":"Clift RA","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1994.01090150102031"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1972.tb04789.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb02887.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1182\/blood.V91.10.3637","article-title":"Long\u2010term outcome after marrow transplantation for severe aplastic anaemia","volume":"91","author":"Deeg HJ","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood.V85.8.2263.bloodjournal8582263","article-title":"Allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: a randomized trial of busulphan\u2010Cytoxan versus Cytoxan\u2010total body irradiation as preparative regimen. (A French Society of Bone Marrow Grafts (SFGM) report.)","volume":"85","author":"Devergie A","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(83)34600-5"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4827(66)90289-8"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(88)33198-2"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00920023"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(67)90086-5"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1989.37"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(69)90722-3"},{"key":"e_1_2_6_22_1","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1681\/ASN.V75792","article-title":"Randomized study with cyclosporin in kidney transplantation: 10\u2010year follow\u2010up","volume":"7","author":"Ponticelli C","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5794.218"},{"key":"e_1_2_6_24_1","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood.V93.7.2196","article-title":"Increased risk of chronic graft\u2010versus\u2010host disease, obstructive bronchiolitis, and alopaecia with busulphan versus total body irradiation: Long\u2010term results of a randomized trial in allogeneic marrow transplant recipients with leukaemia. (A Nordic Bone Marrow Transplantation Group report.)","volume":"93","author":"Ringd\u00e9n O","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_25_1","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood.V83.9.2723.2723","article-title":"A randomized trial comparing busulphan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukaemia. (A Nordic Bone Marrow Transplantation Group report.)","volume":"83","author":"Ringd\u00e9n O","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(57)90001-6"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000204467"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-12-199312150-00004"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(86)90077-9"}],"container-title":["Acta Ophthalmologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0420.2002.800217.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0420.2002.800217.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0420.2002.800217.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T09:45:05Z","timestamp":1697535905000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0420.2002.800217.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["10.1034\/j.1600-0420.2002.800217.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0420.2002.800217.x","archive":["Portico"],"relation":{},"ISSN":["1395-3907","1600-0420"],"issn-type":[{"value":"1395-3907","type":"print"},{"value":"1600-0420","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}